Sign Up
OverviewAPI
Adicet Bio granted a non-qualified stock option award to a new hire under Nasdaq Listing Rule 5635(c)(4), offering 7,000 shares with a four-year vesting schedule. This award was issued outside of the stockholder-approved equity incentive plans. Adicet Bio specializes in allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.

Ask a question